Developer of a marketplace and discovery platform intended to offer an alternative to the classic model of a gym members
Developer of a marketplace and discovery platform intended to offer an alternative to the classic model of a gym membership.
Human Capital Services📍 New York, NYFounded 2012
Current Valuation
$2.4B
as of 2023-Q3
UNICORN
QL Price
$2.2B
-7% vs last round
QuantLogix's current estimate for Wellhub, published 2026-09-12 — below the last disclosed round of $2.4B (2023-Q3).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$2.4B
2023-Q3
weight 0.13
Secondary market print
$2.2B
2026-06-27
weight 0.63
How this price has held up
No round has priced for Wellhub since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-12 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Wellhub, 2026-09-12 (8282360b8aaebbb0).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Wellhub going public?
No. Wellhub is private and has not filed to go public. There is no S-1 on file.
What is Wellhub's valuation in 2026?
Wellhub is valued at $2.4B as of 2023-Q3, set by its Series F ($85M, Aug 2023). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Wellhub filed an S-1?
No public S-1 is on file for Wellhub.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2012
HQ
New York, NY
Employees
2,294
Last Round
Series F — $85M (Aug 2023)
IPO Status
private
Fundraising Status
Series F · $85M · 3y 1mo ago
private
Secondary Market
Implied price / share
$31.1
Last round price / share
$33.81
vs last round
-8.0%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series F
$85M
Aug 2023
—
$2.4B
Talent Signal
Hiring trend
● First snapshot
trend accrues with monthly sweeps
Open roles
16
via careers page
Product-build share
13%
engineering, research, product, design
Trajectory
steady
go-to-market push — Only 13% of open roles build product — hiring is concentrated in sales/marketing/ops (6 of 16 open roles are operations).
Actively hiring with no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Ionis PharmaceuticalsUniversity Medical Center of Southern NevadaPartner with Wellhub\\ \\ Boost membership & revenueBlog\\ \\ Get guidance & insights to support healthier teamsCorporate Newsletter\\ \\ Stay up-to-date with our HR newsletterLearn how HR leaders manage increased burnout and sustain AI output
Counted from Wellhub's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Human ResourcesEmployee BenefitsFitnessWellnessConsumer Goods & Software
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2023-Q3. Refreshed quarterly.